Laurence Bouillet
Immunology — Centre Hospitalier Universitaire de Grenoble, France
Laurence Bouillet
LeadR Profile
Immunology
Subspecialties: Hematology - Internal Medicine - Dermatology
Main Topics
Publications and Clinical Studies
Organizations
Centre Hospitalier Universitaire de Grenoble -
Publications Synthesis
Source: Pubmed
Number : 533
Citations
Main journals
Best Journals
Breakdown by type
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial. skin, safety, pain, pharmaceutical preparations, angioedemas, hereditary, drug-related side effects and adverse reactions, capsules, bradykinin, therapeutics, angioedema, hematologic diseases | Lancet Haematol | 2026 | 0 |
| International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema. genetic testing, rare diseases, hypersensitivity, angioedemas, hereditary, signs and symptoms, bradykinin, diagnosis, therapeutics, angioedema | Allergy | 2026 | 0 |
| Spectrum and significance of 18F-FDG-PET/CT abnormalities in VEXAS syndrome. bone marrow, lymph nodes, positron emission tomography computed tomography, rheumatic diseases, fluorodeoxyglucose f18, lymph | Rheumatology (Oxford) | 2026 | 0 |
| Diagnostic Delay in Patients With Chronic Urticaria: Results From the Chronic Urticaria Registry (CURE). registries, chronic urticaria, hypersensitivity, urticaria, diagnosis, chronic inducible urticaria | Clin Exp Allergy | 2026 | 0 |
| Real-World Effectiveness and Safety of Fostamatinib in Difficult-to-Treat Immune Thrombocytopenia Patients. A Prospective, Multicenter Registry in France. registries, hematology, safety, hemorrhage, pharmaceutical preparations, drug-related side effects and adverse reactions, therapeutics, thrombocytopenia, purpura, thrombocytopenic, idiopathic | Am J Hematol | 2026 | 0 |
Clinical Studies 25
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 11
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Efficacy and Tolerance of Abacavir Lamivudine Treatment in Patients With Systemic Lupus Erythematosus NCT06356740 — chorionic gonadotropin, hepatitis c, pilots, blood, hepatitis b virus, hypersensitivity, lamivudine, retroviridae, genome, tablets, nucleosides, rna-directed dna polymerase, lupus erythematosus, systemic, herpesvirus 1, cercopithecine, hiv, viruses, interferon-alpha, leukocytes, hla antigens, autoimmune diseases, gonadotropins, research, therapeutics, hla-b antigens, hepatitis b, reverse transcriptase inhibitors, hematologic tests, dna, hepatitis, rna, allergy, abacavir | Phase 2 | Not yet recruiting | 2024 |
| Epidemiological Data on Mast Cell Pathologies in France NCT06186856 — cells, leukemia, mast-cell, pathology, mastocytosis, mast cells | N/A | Recruiting | 2024 |
| Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis NCT04789850 — sclerosis, safety, scleroderma, systemic | Phase 2 | Recruiting | 2023 |
| NTLA 2002 in Adults With Hereditary Angioedema (HAE) NCT05120830 — genes, clustered regularly interspaced short palindromic repeats, safety, saline solution, angioedemas, hereditary, gene editing, angioedema, pharmacokinetics, lipid nanoparticles | Phase 1/Phase 2 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map